# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-25-004221
Filing Date
2025-01-16
Accepted
2025-01-16 16:30:15
Documents
18
Period of Report
2025-01-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRELIMINARY PROXY STATEMENT | ea0227318-pre14a_citius.htm iXBRL | PRE 14A | 516098
2 | GRAPHIC | image_001.jpg | GRAPHIC | 86775
3 | GRAPHIC | image_002.jpg | GRAPHIC | 369291
4 | GRAPHIC | image_003.jpg | GRAPHIC | 640951
| Complete submission text file | 0001213900-25-004221.txt |  | 4155633

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | ctxr-20250109.xsd | EX-101.SCH | 11027
6 | XBRL DEFINITION FILE | ctxr-20250109_def.xml | EX-101.DEF | 5386
7 | XBRL LABEL FILE | ctxr-20250109_lab.xml | EX-101.LAB | 36765
8 | XBRL PRESENTATION FILE | ctxr-20250109_pre.xml | EX-101.PRE | 7756
20 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0227318-pre14a_citius_htm.xml | XML | 206104

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 001-38174 | Film No.: 25535996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)